Bayer Invests in German Pharma Manufacturing
Bayer looks set to pump more resources into its German operations with the announcement of an investment of $1.53 billion. The cash is going to be used to grow manufacturing operations in Bergkamen, Berlin, Leverkusen, Weimar and Wuppertal and to create greater scope for innovation. One key target for Bayer is modernisation of facilities and being able to integrate more digital technologies, as well as investing in more innovative research methods. The company is also looking to establish strong links...
View full press release